- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 8.33M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.88M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 4.83M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $9.21K |
| Capex | Q1 2026 · Mar 31, 2025 | $1.81K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.3M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $6.35M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $5.82M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$31.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$34.25M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.57M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.23M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $42.4M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $42.49M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.52M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.06M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.04M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.9M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.97 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.63M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.24M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.85M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.61M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.66M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.42M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.35M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.52M |
| Revenue | Q1 2026 · Mar 31, 2026 | $985.08K |
| Revenue | Q1 2026 · Mar 31, 2025 | $246.39K |